While it is unclear whether any microbial interventions will do this, incretin-based therapies are extensively used for the treatment of hyperglycemic disorders such as T2DM but may not be safe or effective for use in pregnancy. This evidence concerns the gene GCG and type 2 diabetes mellitus.